← Leaderboards
Adriaan Willem Bruijnzeel
University Of Florida
$4,827,220
Attributed
$5,032,345
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $603.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,032,345 · 7
By mechanism
R01$4,189,155 · 3
R03$432,940 · 3
R21$410,250 · 1
Top collaborators
- Barry Setlow2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Julie A Marusich$2,280,423
- Minghong Ma$15,633,699
- Daniel W Wesson$7,277,661
- Neil Edward Rowland$910,454
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusBrainSmokingRelapseRewardsSelf StimulationProceduresNicotineSmoking CessationBasePreventNeuronsMediatingWithdrawalPlayExposure ToSignal TransductionSmokerBehaviorResearch StudyStressNeuropeptidesNicotine WithdrawalChronic
Grant awards (21)
Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats$343,125
R01 · FY2024 · DA · contact PI
Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats$343,125
R01 · FY2022 · DA · contact PI
Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats$343,125
R01 · FY2021 · DA · contact PI
Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats$343,125
R01 · FY2020 · DA · contact PI
Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats$328,950
R01 · FY2019 · DA · contact PI
Tobacco: relationship between reduced nicotine content and reinforcement in rats$325,317
R01 · FY2018 · DA · contact PI
Tobacco: relationship between reduced nicotine content and reinforcement in rats$375,442
R01 · FY2017 · DA · contact PI
Tobacco: relationship between reduced nicotine content and reinforcement in rats$380,597
R01 · FY2016 · DA · contact PI
Lasting behavioral and neuroimaging consequences of adolescent exposure to cannabis smoke.$222,750
R21 · FY2016 · DA
Lasting behavioral and neuroimaging consequences of adolescent exposure to cannabis smoke.$187,500
R21 · FY2015 · DA
Nicotine withdrawal and relapse: role of neuroadaptations in brain stress systems$281,368
R01 · FY2012 · DA · contact PI
Nicotine withdrawal and relapse: role of neuroadaptations in brain stress systems$281,368
R01 · FY2011 · DA · contact PI
Nicotine withdrawal and relapse: role of neuroadaptations in brain stress systems$290,070
R01 · FY2010 · DA · contact PI
Nicotine dependence and central adiposity signaling$73,250
R03 · FY2010 · DA · contact PI
Nicotine withdrawal and relapse: role of neuroadaptations in brain stress systems$286,025
R01 · FY2009 · DA · contact PI
Nicotine dependence and central adiposity signaling$73,250
R03 · FY2009 · DA · contact PI
Nicotine withdrawal and relapse: role of neuroadaptations in brain stress systems$267,518
R01 · FY2008 · DA · contact PI
Role of CRF in the affective symptoms of acute and protracted ethanol withdrawal$70,640
R03 · FY2007 · AA · contact PI
Role of CRF in the affective symptoms of acute and protracted ethanol withdrawal$73,250
R03 · FY2006 · AA · contact PI
Neuropeptide-based therapies for nicotine dependence$71,040
R03 · FY2006 · DA · contact PI
Neuropeptide-based therapies for nicotine dependence$71,510
R03 · FY2005 · DA